Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing therapeutics to modify the course of cardiopulmonary diseases namely, ...

On a recent day at Discovery Place Science, dozens of middle school students walked through the museum's doors curious about ...

A new research paper was published in Volume 17 of Oncotarget on March 17, 2026, titled "CREB5 regulates stem cell-like ...

Autoantibodies in paediatric transplant patients reflect immune recovery but do not predict chronic graft versus host disease ...

It is well known that chronic inflammation can increase a person’s cancer risk, but the underlying mechanisms remain unknown. Now, a new study reveals, in a mouse model of colitis, gut tissues may ...

Chronic inflammation can raise a person's risk of cancer, and a new study reveals key details about how that might happen in ...

We determined that CREB5 is a key regulator of basal and SCL transcriptional programs and tumor-forming phenotypes in PC."BUFFALO, NY – March 24 ...

F.C. School Board to Align With State Cell Phone Policy A policy passed by the Virginia State Legislature that awaits the ...

One of the most puzzling aspects of common chronic inflammatory skin diseases such as psoriasis is how they become chronic.

New neuroscience research identifies Glutamine Synthetase as the key enzyme driving postnatal brain maturation and neuronal ...

Anne-Catherine Bédard is a distinguished research scientist and Founder of Labcoat & Leggings, a platform dedicated to ...